Vemurafenib (PLX4032, Zelboraf®), a BRAF Inhibitor, Modulates ABCB1-, ABCG2-, and ABCC10-Mediated Multidrug Resistance. (2013). Journal of Cancer Research Updates, 2(4),  306-317. https://doi.org/10.6000/1929-2279.2013.02.04.9